Testing an oral extract for spinocerebellar ataxia
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether an oral extract from a mushroom called Antrodia cinnamomea can help improve symptoms in people with spinocerebellar ataxia (a condition that affects coordination and balance). Participants must be able to communicate in Chinese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 70 years old.
- You have been diagnosed with spinocerebellar ataxia (a condition affecting coordination).
- Your ataxia symptoms are not too severe (score below 30 on a standard rating scale).
- You can read, write, and speak Chinese.
- You have not taken any products containing Antrodia cinnamomea in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information from adults with certain types of inherited ataxia caused by specific genetic diagnoses. It may help doctors better understand these conditions and support future research.
This trial looks for eye problems in people with certain genetic forms of spinocerebellar ataxia (SCA1, SCA2, SCA3, or SCA27B). You have to be between 18 and 80 years old and have a specific genetic mutation. You can join if you already have symptoms or if you are at risk but do not have symptoms yet.
This study tests a single injection of umbilical cord stem cells for adults with spinocerebellar ataxia, a condition that affects balance and coordination. The goal is to see if it can slow down or improve symptoms.
This is an observational study that follows people with cerebellar ataxia, their relatives, and healthy volunteers to learn more about the condition. It may help researchers better understand the causes and patterns of cerebellar ataxia over time.
This study tests whether a non-invasive brain stimulation treatment (called cerebellar transcranial magnetic stimulation) can help improve balance and coordination in people with spinocerebellar ataxia. It may offer a new way to ease symptoms without surgery.
This study tests a new treatment using special cells (stem cells) and their tiny particles (exosomes) to see if they are safe and help improve symptoms. It is for people with spinocerebellar ataxia, a condition that affects movement and coordination.
Hear when a new Spinocerebellar Ataxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.